Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 312
Selected: 0
NCT IDTitle
NCT03175835Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT02627027A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
NCT04867720Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients
NCT04345796Pharmacological Reduction of Right Ventricular Enlargement
NCT06386328A Clinical Trial to Evaluate the Food Effect of CKD-378
NCT02854748Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
NCT06492655To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
NCT05452525Pharmacokinetics and Safety/Tolerability Profile of CKD-379
NCT02064556CKD-330 Drug-Drug Interaction Study (Amlodipine)
NCT01501253CKD-828 S-Amlodipine Non-Responder Trial
NCT04667975The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
NCT04869800Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
NCT06430047Efficacy and Safety of EsoDuo®
NCT03858725Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
NCT06483243Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.
NCT03414840Assessment of Change in Atherosclerotic Plaque by Serial CCTA
NCT02565368A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers
NCT05571813Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
NCT05193565Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
NCT03793985Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
NCT06758661Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers
NCT04651881Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions
NCT03659149Pharmacokinetics and Safety Profile of CKD-333
NCT04883658A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT05698043A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
NCT02586311CKD-330 Phase 3 Trial in Amlodipine Non-responder
NCT02824874CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)
NCT06121518Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
NCT04539652Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients
NCT04673695A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
NCT04083846Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT03794492Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
NCT02894541Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519
NCT04075643Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
NCT03051841CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT02753504Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT03770052Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
NCT04304547Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
NCT01895894Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
NCT01128322CKD-828 Primary Hypertension Trial(Dose-selection)
NCT07215637Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
NCT03762369A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT05189288Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
NCT02356679Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
NCT06954766Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
NCT02526875Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
NCT04830930A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers
NCT06088017A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)
NCT01560325Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT04334213A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150